Item:Q20437: Difference between revisions

@@ Property / described at URL @@
+https://www.businesswire.com/news/home/20230623446641/en/Vertex-Presents-Positive-VX-880-Results-From-Ongoing-Phase-12-Study-in-Type-1-Diabetes-at-the-American-Diabetes-Association-83rd-Scientific-Sessions
+Normal rank
+language of work or name: English
@@ Property / described at URL @@
+https://www.fiercepharma.com/pharma/after-early-win-type-1-diabetes-vertex-joins-forces-lonza-new-cell-therapy-production-plant
+Normal rank
+language of work or name: English
@@ Property / described at URL @@
+https://www.evaluate.com/vantage/articles/events/conferences/ada-2023-vertex-raises-hopes-type-1-diabetes-cure
+Normal rank
+language of work or name: English
@@ Property / described at URL @@
+https://www.biospace.com/article/vertex-trial-data-shows-two-t1d-patients-reach-insulin-independence-with-cell-therapy
+Normal rank
+language of work or name: English
@@ Property / described at URL @@
+https://www.statnews.com/2023/06/23/vertex-diabetes-cell-therapy-insulin/
+Normal rank
+language of work or name: English
@@ Property / described at URL @@
+https://finance.yahoo.com/news/vertex-lonza-build-dedicated-manufacturing-113000348.html
+Normal rank
+language of work or name: English
@@ Property / described at URL @@
+https://www.claytoncountyregister.com/uncategorized/exploring-the-innovative-drug-discoveries-of-vertex-pharmaceuticals-incorporated/25866/
+Normal rank
+language of work or name: English
@@ Property / Commons category @@
+Vertex Pharmaceuticals
@@ Property / Commons category: Vertex Pharmaceuticals / rank @@
+Normal rank
@@ links / en / name / links / en / name @@
+Vertex Pharmaceuticals